Angiotensin-converting enzyme inhibitor use and pneumonia risk in a general population Source: Eur Respir J 2006; 27: 1217-1222 Year: 2006
Impact of statins, angiotensin-converting enzyme inhibitors (ACEI), and angiotensin receptor blockers (ARBS) on reducing COPD morbidity Source: Annual Congress 2009 - Treatment of airways disease Year: 2009
Impact of statins, angiotensin-converting enzyme inhibitors(ACEI), and angiotensin receptor blockers (ARBs) on reducing COPD morbidity Source: Annual Congress 2010 - COPD: management Year: 2010
Activity and phenotypes of angiotensin-converting enzyme (ACE) in sarcoidosis with various organ involvement Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases Year: 2020
The risk of community-acquired pneumonia and the use of statins, ACE inhibitors and gastric acid suppressants Source: Annual Congress 2008 - Infectious lung diseases including tuberculosis Year: 2008
The influence of angiotensin-converting enzyme (ACE) genotype on the development of severe perinatal asphyxia in the neonates Source: Annual Congress 2011 - Issues in paediatric and neonatal intensive care Year: 2011
A population-based study of statin, ARB, and ACE inhibitor use on pneumonia-related outcomes Source: Annual Congress 2011 - Severity, comorbidities and outcomes in community-acquired pneumonia Year: 2011
Angiotensin-converting enzyme genotype and C-reactive protein in patients with COPD Source: Eur Respir J 2007; 29: 816-817 Year: 2007
Correlation between the use of statins and ACE inhibitors with the length of hospitalization for COPD exacerbations Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010
Respiratory function changes in patients with coronary heart disease after long-term treatment course by β-blockers and angiotensin-converting enzyme inhibitors Source: Eur Respir J 2004; 24: Suppl. 48, 280s Year: 2004
Angiotensin-converting enzyme insertion/deletion polymorphism and risk and outcome of pneumonia Source: Annual Congress 2007 - Prognostic laboratory tests in community-acquired pneumonia Year: 2007
Correlation between angiotensin-converting enzyme (ACE) gene polymorphism and exercise performance in COPD patients Source: Annual Congress 2010 - Exercise in COPD Year: 2010
ACE I/D but not AGT (-6)A/G polymorphism is a risk factor for mortality in ARDS Source: Eur Respir J 2007; 29: 482-488 Year: 2007
Angiotensin-converting enzyme inhibitor prevents aspiration pneumonia by ameliorating swallowing disorder in pharyngeal phase Source: Annual Congress 2003 - New aspects of community acquired pneumonia Year: 2003
Microbial evaluation of proton-pump inhibitors and the risk of pneumonia Source: Eur Respir J 2011; 38: 1165-1172 Year: 2011
Clinical significance of angiotensin converting enzyme (ACE) activity in sarcoidosis Source: Eur Respir J 2001; 18: Suppl. 33, 384s Year: 2001
Effect of long-term angiotensin-converting factor inhibitors on breathing function and hemorheology indices in patients with tuberculosis and COPD Source: Eur Respir J 2001; 18: Suppl. 33, 306s Year: 2001
Angiotensin-converting enzyme 2 expression is not induced by the renin–angiotensin system in the lung Source: ERJ Open Res, 6 (4) 00402-2020; 10.1183/23120541.00402-2020 Year: 2020
Genotype-corrected reference values for serum angiotensin-converting enzyme Source: Eur Respir J 2006; 28: 1085-1091 Year: 2006
Association of outpatient statin, ARB, and ACE inhibitor use on clinical outcomes for elderly subjects hospitalized with severe sepsis Source: Annual Congress 2013 –Interesting research questions Year: 2013